Hydrosalpinx treatment before in‐vitro fertilization: systematic review and network meta‐analysis
Authors:
- F. Pérez‐MilánFPF. Pérez‐Milán
- the Spanish Fertility Society Special Interest Group on Organic Reproductive DisordersTDthe Spanish Fertility Society Special Interest Group on Organic Reproductive Disorders
Open Access
- 26 January 2025
- journal article
- research article
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 65 (4) , 414-426
Abstract
Objective: To compare the safety and effectiveness of different methods, both ablative and non‐ablative, to treat hydrosalpinx in infertile patients before in‐vitro fertilization embryo transfer (IVF‐ET) via a systematic review and network meta‐analysis (NMA).Methods: A structured literature search was conducted in common citation databases. Eligibility criteria included peer‐reviewed randomized controlled trials (RCTs) or cohort studies comparing the effectiveness and/or safety of different hydrosalpinx treatments, including salpingectomy, laparoscopic proximal tubal occlusion (LTO), insertion of an intratubal device (ITD), ultrasound‐guided aspiration, sclerotherapy and expectant management. Primary outcomes were live birth, ongoing pregnancy and clinical pregnancy. Miscarriage, ectopic pregnancy and procedural complications were considered as secondary outcomes. The main NMA included only RCTs, while observational studies were included in a secondary aggregate NMA. Pooled effects were summarized as odds ratios (ORs) with 95% CI for direct and indirect comparisons, derived from random‐effects models. Imprecision of NMA estimates was assessed by comparison of their 95% CIs with predefined thresholds for effect size considered to represent clinical relevance (OR < 0.9 or >1.1). Heterogeneity for NMA findings was estimated using the variance of the distribution of the underlying treatment effects (τ2), expressed as a 95% prediction interval. Surface under the cumulative ranking curve (SUCRA) was used to predict relative treatment rankings for each outcome.Results: The main analysis included nine RCTs, while an additional 17 observational studies were incorporated into the aggregate analysis. The NMA of RCTs revealed no significant differences in live birth rate between hydrosalpinx treatment methods, with LTO achieving the highest SUCRA value (0.9). Salpingectomy and ultrasound‐guided aspiration significantly increased the ongoing pregnancy rate compared with no treatment (OR, 4.35 (95% CI, 1.70–11.14) and 2.80 (95% CI, 1.03–7.58), respectively), with salpingectomy having the highest SUCRA value (0.9). Clinical pregnancy rate was significantly higher following salpingectomy (OR, 2.24 (95% CI, 1.30–3.86)) and LTO (OR, 2.55 (95% CI, 1.20–5.51)) compared with no treatment, despite some heterogeneity; LTO had the highest SUCRA value (0.8). NMA showed no significant differences in secondary outcomes between treatments. Aggregate NMA indicated that sclerotherapy significantly increased the live birth rate compared with no treatment. Higher ongoing pregnancy rate was observed in patients treated with salpingectomy, ultrasound‐guided aspiration and LTO compared to untreated patients, with salpingectomy having the highest SUCRA value (0.9). Except for ITD insertion, all interventions increased the clinical pregnancy rate compared with no treatment. LTO had a greater effect on clinical pregnancy rate compared to ultrasound‐guided aspiration, with no significant differences in other pairwise comparisons. NMA ranked LTO as the most effective treatment for increasing the clinical pregnancy rate and reducing the miscarriage rate, while sclerotherapy was deemed safer with regard to the ovarian response to IVF stimulation.Conclusions: This NMA fails to support the effectiveness of any hydrosalpinx treatment to improve the live birth rate following IVF‐ET, although the beneficial effect of salpingectomy and ultrasound‐guided aspiration on ongoing pregnancy rate and of salpingectomy and LTO on clinical pregnancy rate reinforces current recommendations. Based on the aggregated analysis, sclerotherapy could be an effective alternative to conventional laparoscopic techniques, with a favorable safety profile. © 2024 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.Keywords
This publication has 79 references indexed in Scilit:
- ART Outcomes After Hysteroscopic Proximal Tubal Occlusion Versus Laparoscopic Salpingectomy for Hydrosalpinx Management in Endometriosis PatientsReproductive Sciences, 2021
- Surgical treatment for tubal disease in women due to undergo in vitro fertilisationCochrane Database of Systematic Reviews, 2020
- CINeMA: Software for semiautomated assessment of the confidence in the results of network meta‐analysisCampbell Systematic Reviews, 2020
- Surgical treatment for hydrosalpinx prior to in‐vitro fertilization embryo transfer: a network meta‐analysisUltrasound in Obstetrics & Gynecology, 2016
- High miscarriage rate in women treated with Essure® for hydrosalpinx before embryo transfer: a systematic review and meta‐analysisUltrasound in Obstetrics & Gynecology, 2016
- Hysteroscopic hydrosalpinx occlusion with Essure device in IVF patients when salpingectomy or laparoscopy is contraindicatedEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2013
- Effects of hydrosalpinx on pinopodes, leukaemia inhibitory factor, integrin β3 and MUC1 expression in the peri-implantation endometriumEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2010
- Proximal tubal occlusion and salpingectomy result in similar improvement in in vitro fertilization outcome in patients with hydrosalpinxFertility and Sterility, 2006
- Ovarian response to gonadotropins after laparoscopic salpingectomy or the division of fallopian tubes for hydrosalpingesFertility and Sterility, 2006
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002